| Data | Hora | Fonte | Título | Código | Companhia |
| 14/02/2018 | 18:43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 25/09/2017 | 07:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 12/09/2017 | 08:32 | PR Newswire (US) | 3ST Research Files Litigation Alleging Fraud and Conversion of Inventor's Intellectual Property Rights by Albany Molecular Re... | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 05/09/2017 | 18:12 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 05/09/2017 | 17:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 17:01 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 14:38 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 14:38 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 14:29 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 14:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 31/08/2017 | 13:30 | PR Newswire (US) | AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 17/08/2017 | 18:47 | PR Newswire (US) | Control4 Set to Join S&P SmallCap 600 | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 09/08/2017 | 15:36 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 04/08/2017 | 17:30 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 14/07/2017 | 18:26 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 05/07/2017 | 17:51 | PR Newswire (US) | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 03/07/2017 | 18:32 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 29/06/2017 | 09:00 | PR Newswire (US) | AMRI Announces Early Termination of HSR Waiting Period for The Carlyle Group and GTCR's Proposed Acquisition of AMRI | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 09/06/2017 | 14:42 | PR Newswire (US) | WeissLaw LLP: The Proposed Acquisition of Albany Molecular Research Inc. May Not Be In the Best Interest of AMRI Shareholders | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 07/06/2017 | 07:50 | PR Newswire (US) | Stocks Under Scanner in the Biotech Space -- Paratek Pharma, Verastem, Alnylam Pharma, and Albany Molecular Research | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 06/06/2017 | 08:30 | PR Newswire (US) | AMRI Signs Definitive Agreement To Be Acquired By The Carlyle Group and GTCR for $21.75 per share in cash | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 02/06/2017 | 10:15 | PR Newswire (US) | AMRI to Present at Jefferies Healthcare Conference | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 10/05/2017 | 07:05 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 09/05/2017 | 08:30 | PR Newswire (US) | AMRI Announces First Quarter 2017 Results | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 02/05/2017 | 09:00 | PR Newswire (US) | AMRI Receives NIH Contract Award for Drug Substance Development and Manufacturing Services | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 26/04/2017 | 09:00 | PR Newswire (US) | SSCI Receives a 2017 Biotechnology Award for Global Research and Manufacturing | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 25/04/2017 | 09:00 | PR Newswire (US) | AMRI Schedules First Quarter 2017 Earnings Release and Conference Call | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 24/04/2017 | 08:00 | PR Newswire (US) | Denovo Biopharma Obtains Exclusive License To Liafensine From AMRI | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 19/04/2017 | 17:41 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:AMRI | Albany Molecular Research, Inc. |
| 22/03/2017 | 15:38 | PR Newswire (US) | AMRI Receives CMO Leadership Awards for Excellence | NASDAQ:AMRI | Albany Molecular Research, Inc. |